Altering and analyzing glucose metabolism in perfused hearts of transgenic mice.
Glucose metabolism plays an important role in cardiac bioenergetics that changes under various stress conditions including hypertrophy, diabetic cardiomyopathy, and ischemia-reperfusion injury. To understand the role of glycolysis under these conditions, we have altered several steps of the glycolytic pathway specifically in the heart. In this chapter, we describe methods used to produce cardiac-targeted transgenic mice and procedures for measuring various glucose metabolites including glucose-6-phosphate, fructose-6-phosphate, fructose-1,6-bisphosphate, and glycogen. Also, we describe methods for measuring glucose transport and glycolysis in perfused mouse hearts. Using these methods, we show that mice over-expressing cardiac-specific kinase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (Mykd-PFK-2) show reduced glucose transport and reduced glycolysis when compared with control. The metabolites glucose-6-phosphate, fructose-6-phosphate, and glycogen were elevated, whereas fructose-1,6-bisphosphate was reduced in the transgenic Mykd-PFK-2 mouse hearts.
Donthi
Rajakumar V
RV
Department of Pediatrics, Diabetes Research, University of Louisville, School of Medicine, Louisville, Kentucky, USA.
Epstein
Paul N
PN
D000818:Animals; D005947:Glucose / Q000378:metabolism*; D006019:Glycolysis / Q000502:physiology*; D006321:Heart / Q000502:physiology*; D051379:Mice; D008822:Mice, Transgenic; D010477:Perfusion / Q000295:instrumentation / Q000379:methods; D019076:Transgenes
D005947:Glucose